Exercise tolerance and dyspnea in patients with chronic obstructive pulmonary disease;Tolerisanje napora i dispnoja kod bolesnika sa hroničnom opstruktivnom bolešću pluća

Vojnosanitetski Pregled

Volumn 67, Issue 1, 2010, Pages 36-41

  Čekerevac, Ivan ^a   Lazić, Zorica ^a   Novković, Ljiljana ^a   Petrović, Marina ^a   Ćupurdija, Vojislav ^a   Kitanović, Gordana ^b   Todorović, Zoran ^c   Gajović, Olgica ^a  

^a Centar za Plu ne Bolesti   (Serbia)

^b Klini ki centar Kragujevac   (Serbia)

^c Kragujevac   (Serbia)

Author keywords

Exertion; Muscular disorders, atrophic; Nutrition disorders; Pulmonary disease, chronic obstructive; Respiratory function tests

Indexed keywords

ADULT; AGED; AIRFLOW; ARTICLE; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMAN; HYPERINFLATION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MALE; MUSCLE WEAKNESS; NUTRITIONAL DISORDER; NUTRITIONAL STATUS; PLETYSMOGRAPHY; SKELETAL MUSCLE; SPIROMETRY; WALKING;

EID: 75749152651     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1001036C     Document Type: Article

References (14)

1. Marin J , Carrizo M, Gascon M, Sanzhez A, Gallego B. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1395-99.
2. Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should). Proceedings of the ATS 2007; 4(7): 522-25.
3. Polkey MI. Peripheral muscle weakness in COPD: where does it come from? Thorax 2003; 58(9): 741-42.
4. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26(4): 703-19.
5. Wagner D. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 2008; 31(3): 492-501.
6. Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, Belleau R, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 629-34.
7. Eisner M, Iribarren C, Yelin E, Sidney S, Katz P, Ackerson L, et al. Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease. Am J Epidemiol 2008; 167(9): 1090-101.
8. Debigare R, Cote CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med 2001; 164: 1712-17.
9. Mattson P, Martin J. Emphysema-induced reductions in locomotory skeletal muscle contractile function. Exp Physiol 2005; 90(4): 519-25.
10. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005; 26(4): 703-19.
11. Montes de Oca M, Loeb E, Torres S, De Sanctis J, Hernandez N, Talamo C. Peripheral muscle alterations in non-COPD smokers. Chest 2008; 133(1): 13-8.
12. Jagoe R, Engelen M. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 52-63.
13. Heymsfield SB, McManus C, Smith J, Stevens V, Nixon DW. Anthropometric measurements of muscle mass: revised equations for calculating bone-free muscle area. Am J Clin Nutr 1982; 36: 680-90.
14. Sahebjami H, Sathianpitayakul E. Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 172: 886-90.